HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dermasorb versus Jelonet in patients with burns skin graft donor sites.

Abstract
A prospective and randomized trial that compares Jelonet (Smith & Nephew PLC, London, England) with a new hydrocolloid dressing, Dermasorb (Convatec Ltd., Clwyd, United Kingdom), is presented. The dressings were applied on contiguous donor sites in 21 patients that required skin grafting for burn wounds. Pain experienced with the dressing in situ was assessed on days 2, 4, 7, and on two subsequent occasions. During dressing changes, pain experienced was again assessed, bacteriologic swabs were taken, and the percentage of epithelialization was recorded. Questionnaires completed by investigators and patients were used to assess the perceived performances of both dressings. The results showed that Dermasorb is a less painful dressing than Jelonet, in which wounds heal faster. Dermasorb was preferred by both investigators and patients. No clinical or laboratory evidence of any differences of colonization or infection were found. All results were statistically significant. We would strongly recommend the use of Dermasorb as a split-thickness skin graft donor site dressing for a patient with burns.
AuthorsM A Cadier, J A Clarke
JournalThe Journal of burn care & rehabilitation (J Burn Care Rehabil) 1996 May-Jun Vol. 17 Issue 3 Pg. 246-51 ISSN: 0273-8481 [Print] United States
PMID8736372 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Colloids
  • Organic Chemicals
  • dermasorb
  • jelonet
  • Petrolatum
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Bandages
  • Burns (surgery)
  • Colloids (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Occlusive Dressings
  • Organic Chemicals
  • Petrolatum
  • Prospective Studies
  • Skin Transplantation (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: